Verapamil

CHEMBL6966 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
454.6 g/mol
LogP
3.8
Phase
4

This calcium channel blocker is used to treat high blood pressure, certain heart rhythm disorders (including atrial fibrillation and supraventricular tachycardia), and angina (chest pain), and is also used to prevent migraine headaches and cluster headaches. It works by slowing the movement of calcium into heart and blood vessel muscle cells, causing the heart to beat more slowly and blood vessels to relax. It interacts with many medications, and grapefruit juice can increase its blood levels significantly.

Berat Molekul

454,6000 g/mol

LogP

3,80

TPSA

64,00 Ų

Lipinski RO5

Lulus

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC

InChI

InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3

Molecular Formula

C27H38N2O4

HBD / HBA

- / 6

Ikatan yang Dapat Dirotasi

13

Atom Berat

33

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This calcium channel blocker is used to treat high blood pressure, certain heart rhythm disorders (including atrial fibrillation and supraventricular tachycardia), and angina (chest pain), and is also used to prevent migraine headaches and cluster headaches. It works by slowing the movement of calcium into heart and blood vessel muscle cells, causing the heart to beat more slowly and blood vessels to relax. It interacts with many medications, and grapefruit juice can increase its blood levels significantly.

Yes, Verapamil is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6966. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2520. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.